Advisory Alpha LLC Acquires 439 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Advisory Alpha LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 2,147 shares of the medical equipment provider’s stock after buying an additional 439 shares during the quarter. Advisory Alpha LLC’s holdings in Intuitive Surgical were worth $1,121,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. LVW Advisors LLC lifted its position in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 19 shares in the last quarter. Hazlett Burt & Watson Inc. boosted its holdings in Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. increased its stake in Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after buying an additional 20 shares in the last quarter. Fragasso Financial Advisors Inc lifted its position in shares of Intuitive Surgical by 3.0% in the fourth quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock valued at $359,000 after acquiring an additional 20 shares in the last quarter. Finally, Ullmann Wealth Partners Group LLC grew its position in shares of Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. Truist Financial upped their target price on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Citigroup increased their price target on Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Royal Bank of Canada upped their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $610.45 on Thursday. The business’s 50 day moving average price is $543.14 and its 200-day moving average price is $501.89. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $614.72. The company has a market cap of $217.43 billion, a price-to-earnings ratio of 98.14, a PEG ratio of 5.04 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 1,012 shares of the business’s stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $514.00, for a total transaction of $520,168.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,830,084. This represents a 15.53 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,487 shares of company stock worth $22,590,975 in the last 90 days. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.